ClinicalTrials.gg

Ischemia clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 545 studies for Ischemia across more than 10 countries. 72 are recruiting or about to start. 201 of them are mainly about Ischemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 15 narrower conditions too, such as Myocardial Infarction: 4,578 studies, 927 open.

ClinicalTrials.gov finds 16,631 studies for Ischemia. How that becomes 545 here

This page counts the studies the registry files under Ischemia, and those it files under no condition that list Ischemiathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 16,631Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −3,689Filed under a narrower condition, counted on its own pageMyocardial Infarction 1,932 · ST Elevation Myocardial Infarction 631 · Chronic Limb-Threatening Ischemia 336 · Shock, Cardiogenic 249 · Cerebral Infarction 189 · Non-ST Elevated Myocardial Infarction 107 · 9 more
  3. −839List Ischemia as a condition, but the registry did not file them under itMost often written as “Myocardial Ischemia” (338), “Brain Ischemia” (63), and “Ischemia Reperfusion Injury” (44). The registry filed 37 of them under no condition at all, and the others under other conditions only, most often Myocardial Ischemia (353) and Coronary Artery Disease (169).
  4. −11,558Match it another way380 name it in the title, 258 in a keyword, and 10,920 by a synonym or other text the search reads.
  5. 545The count on this page75 of them list Ischemia in their own words; the registry filed them under no condition.

Status

Completed
292
Status unknown
97
Recruiting
45
Terminated
44
Not yet recruiting
27
Withdrawn
18

Phase

Phase 2
78
Phase 3
54
Phase 1
50
Phase 4
38
Early Phase 1
3

Where

United States
155
France
53
Germany
46
China
39
Canada
27
Spain
27

Who develops what

Add Ischemia to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 4 programs from 3 companies, 4 with this as their studies’ main aim; 0 with a live phase 3 study; 0 primary completions in the next 12 months. Compare Jiangsu HengRui Medicine and Research here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 4 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Ischemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Thrombolytics 6 · Statins 6 · Inhaled anesthetics 4 · P2Y12 inhibitors 4

Coming up

28studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 45 Ischemia studies recruiting now, 35 (78%) set no upper age limit and 5 (11%) stop at 75 or younger. 4 (9%) take children under 18. 0 (0%) are for women only and 1 (2%) for men only; 7 (16%) take healthy volunteers.

Recruiting studies that take each age, of 45
AgeWomenMen
103 (7%)4 (9%)
1836 (80%)37 (82%)
3038 (84%)39 (87%)
4042 (93%)43 (96%)
5041 (91%)41 (91%)
6541 (91%)41 (91%)
7540 (89%)40 (89%)
8539 (87%)39 (87%)

Across all 545 studies, recruiting or not: 17% stop at 75 or younger and 10% at 65; 8% take children; 2% are for women only and 3% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ischemia studies take

Of 12 phase 3 interventional studies under Ischemia, half reached primary completion within 40 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 340 mo21–51 · 12 studies——
Interventional, no phase33 mo16–48 · 82 studies—33 mo16–46 · 71 studies
Observational35 mo22–68 · 70 studies—55 mo24–… · 48 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 545. Browse all 545 → or search them.